Inicio Productos Suministros para pruebas médicas

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Name: Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection
Brand: Sichuan Hundred Medcal Technology Co., Ltd.
SKU: /
Availability: InStock

Todos los productos

Dispositivo médico para el hogar
(42)

Suministros de protección médica
(13)

Dispositivo dental médico
(23)

Consumibles para cirugía
(35)

Analizador Médico
(12)

Suministros para pruebas médicas
(19)

equipos de diagnóstico médico
(41)

Equipo de rescate de emergencia
(13)

equipo de terapia respiratoria
(5)

equipo de vigilancia medica
(10)

Productos médicos para la salud
(25)

Fuentes heridas del cuidado
(6)

Equipo de esterilización médica
(1)

Equipo médico de rehabilitación
(14)

Equipo Hiperbárico
(2)

Certificación

Porcelana Sichuan Hundred Medcal Technology Co., Ltd. certificaciones

Estoy en línea para chatear ahora

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Ampliación de imagen : Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Datos del producto:

Lugar de origen:	Porcelana
Nombre de la marca:	HDRMEDICO
Certificación:	CE
Número de modelo:	/

Pago y Envío Términos:

Cantidad de orden mínima:	500 piezas
Precio:	Negociable
Detalles de empaquetado:	Caja de cartón
Tiempo de entrega:	10-15 días
Condiciones de pago:	L/C, T/T, Westen Union, Money Gram, PayPal/VTB
Capacidad de la fuente:	100000 piezas/mes

Contacto Ahora Charle

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

descripción

Nombre del producto:	Casete de prueba rápida del virus chikungunya	Material:	Plástico
Categoría de producto:	Diagnóstico in vitro	Método:	Método del oro coloidal
Duración:	dos años	Función:	Detección
Resaltar:	Chikungunya virus rapid test cassette , Colloidal gold antibody detection test , IgM IgG rapid test cassette

Chikungunya Virus Rapid Test Cassette

This in vitro diagnostic device utilizes immunochromatographic (colloidal gold) technology for the rapid, qualitative detection of anti-Chikungunya virus IgM and IgG antibodies in human serum, plasma, or whole blood samples.

Technology & Methodology

The test operates on a lateral flow immunoassay principle. Recombinant Chikungunya virus antigens are immobilized on the nitrocellulose membrane at distinct test lines (T-IgM and T-IgG). When a sample is applied, anti-CHIKV antibodies bind to the antigen-colloidal gold conjugate, forming visible colored lines at the respective test lines.

Intended Use & Clinical Applications

This rapid test serves as an important aid in the presumptive diagnosis of recent or past Chikungunya virus infection, particularly useful in:

Outbreak Settings: Rapid screening of febrile patients in areas with active CHIKV transmission
Differential Diagnosis: Distinguishing Chikungunya fever from other clinically similar arboviral diseases such as dengue or Zika virus infection
Case Management: Supporting clinical decision-making for patients with acute onset of high fever and severe joint pain

Key Features & Advantages

Rapid Results: Visual results typically within 10-20 minutes for quick clinical triage
Simultaneous Detection: Detects both IgM (recent infection) and IgG (later stage or past infection) antibodies from a single sample
Ease of Use: Simple procedure requiring minimal training and no specialized laboratory equipment
High Clinical Utility: Positive IgM result with compatible symptoms strongly suggests acute Chikungunya infection

Result Interpretation

Result	Interpretation
IgM Positive	Suggests recent or current Chikungunya virus infection
IgG Positive	Indicates later-stage or past infection/exposure
Both IgM & IgG Positive	Common during the convalescent phase
Negative	No detectable levels of anti-CHIKV antibodies (does not completely rule out early infection)
Invalid	Control line (C) fails to appear - test must be repeated

Important Notes

This is a screening test. All reactive results, especially in low-prevalence areas, should be confirmed by more specific serological methods (ELISA, PRNT) or molecular tests (RT-PCR) in a reference laboratory. Test performance may vary depending on sample collection timing relative to symptom onset. Clinical history and epidemiological context are essential for accurate diagnosis.

etiqueta:

Persona de Contacto: Mr. Terry

Teléfono: 15008220675

Otros productos